Pure Biologics Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Pure Biologics.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | 31.1% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Here's Why We're Watching Pure Biologics Spólka Akcyjna's (WSE:PUR) Cash Burn Situation
Dec 06We Think Pure Biologics Spólka Akcyjna (WSE:PUR) Can Afford To Drive Business Growth
Aug 14Will Pure Biologics Spólka Akcyjna (WSE:PUR) Spend Its Cash Wisely?
Apr 30We Think Pure Biologics Spólka Akcyjna (WSE:PUR) Can Afford To Drive Business Growth
Jan 03We're Interested To See How Pure Biologics Spólka Akcyjna (WSE:PUR) Uses Its Cash Hoard To Grow
Apr 21In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Pure Biologics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2023 | 0 | -32 | -28 | -25 | N/A |
6/30/2023 | 0 | -31 | -32 | -29 | N/A |
3/31/2023 | 1 | -26 | -29 | -25 | N/A |
12/31/2022 | 1 | -26 | -23 | -17 | N/A |
9/30/2022 | 1 | -19 | -21 | -18 | N/A |
6/30/2022 | 1 | -17 | -16 | -14 | N/A |
3/31/2022 | 0 | -15 | -12 | -10 | N/A |
12/31/2021 | 0 | -12 | -25 | -24 | N/A |
9/30/2021 | 0 | -15 | -18 | -18 | N/A |
6/30/2021 | 0 | -14 | -14 | -13 | N/A |
3/31/2021 | 0 | -13 | -9 | -8 | N/A |
12/31/2020 | 1 | -12 | -2 | -1 | N/A |
9/30/2020 | 1 | -9 | 8 | 8 | N/A |
6/30/2020 | 1 | -7 | 9 | 9 | N/A |
3/31/2020 | 2 | -6 | 3 | 3 | N/A |
12/31/2019 | 2 | -4 | 7 | 7 | N/A |
9/30/2019 | 2 | -3 | -4 | -4 | N/A |
6/30/2019 | 2 | -2 | -5 | -4 | N/A |
3/31/2019 | 2 | -1 | -3 | -3 | N/A |
12/31/2018 | 1 | -1 | -3 | -2 | N/A |
9/30/2018 | 1 | 0 | -5 | -5 | N/A |
12/31/2017 | 1 | 0 | -3 | -3 | N/A |
12/31/2016 | 1 | 0 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if PUR's forecast earnings growth is above the savings rate (3.6%).
Earnings vs Market: Insufficient data to determine if PUR's earnings are forecast to grow faster than the Polish market
High Growth Earnings: Insufficient data to determine if PUR's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if PUR's revenue is forecast to grow faster than the Polish market.
High Growth Revenue: Insufficient data to determine if PUR's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PUR's Return on Equity is forecast to be high in 3 years time